Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study)

• Status: NOT_YET_RECRUITING
• Trial end date: 2026-12-31

Summary

This study aims to evaluate the effect of co-administering the probiotic Saccharomyces boulardii CNCM I-745 with amoxicillin-clavulanic acid on the intestinal and nasopharyngeal microbiota in children diagnosed with acute otitis media or acute bacterial sinusitis. The trial will also assess the potential of the probiotic to reduce antibiotic-associated diarrhea (AAD), antibiotic associated microbiota perturbation, and the spread of antibiotic resistance genes (ARGs).

• Phase: PHASE4

Details

• Lead Sponsor: Eskisehir Osmangazi University
• Collaborator: Turkish Pediatric Probiotic Prebiotic and Microbiota Society
• Treatments: Amoxicillin-Potassium Clavulanate Combination; Suspensions